OPKO Health, Inc.

📍 Miami, United States🗓 Founded 2007👥 310 employees💰 Last funded Sep 2024
Biotechnology Research🌐 opko.com
Website LinkedIn
At OPKO Health, we seek to serve unmet patient needs through our first in class products, comprehensive diagnostics laboratories, robust research and development pipeline, and unique pharmaceutical business solutions. The entrepreneurial acumen of our founder and CEO, Dr. Phillip Frost, has led to the development of a diverse healthcare company flexible enough to adapt to evolving patient needs. We are proud of our first in class products, Rayaldee® (calcifediol), and the 4Kscore® test, as well as our diagnostics division, BioReference Laboratories and GeneDx. In addition to our clinical products and diagnostics, we have a robust research and development pipeline and a variety of biomedical and pharmaceutical business solutions. Since our founding in 2007, OPKO has grown into a global healthcare company, with over 5500 employees spanning nine countries, through organic growth and complementary acquisitions. More information available at www.opko.com.
2
Total investors
1
Early stage
0
Mid stage
0
Late stage
2007
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Liechtenstein
1
Frequently asked questions
Who invested in OPKO Health, Inc.?
OPKO Health, Inc. has 2 investors on record on gritt.io, including 1 early-stage backers.
When did OPKO Health, Inc. last raise funding?
The most recent investment in OPKO Health, Inc. recorded on gritt.io was in September 2024.
When was OPKO Health, Inc. founded?
OPKO Health, Inc. was founded in 2007.
What industry is OPKO Health, Inc. in?
OPKO Health, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is OPKO Health, Inc. based?
OPKO Health, Inc. is headquartered in Miami, United States.